Arslan Ayşe, Tüzün Fatma Aykan, Arslan Harun, Demir Halit, Tamer Sibel, Demir Canan, Tasin Muhterem
Department of Biochemistry, Faculty of Science, Yuzuncu Yil University, Van, Turkey.
Department of Neurology, Private Kocaeli Hospital Center, Kocaeli, Turkey.
Neurol Neurochir Pol. 2016 Nov-Dec;50(6):403-409. doi: 10.1016/j.pjnns.2016.07.002. Epub 2016 Jul 26.
Low paraoxonase 1 (PON1) activity and carotid atherosclerosis have been suggested to be important risk factors for dementia. However, the studies to date could not fully clarify the relationship between PON1, carotid atherosclerosis and dementia. The present study aimed to measure carotid atherosclerosis and PON1 activity in Alzheimer's Disease and to evaluate the relationship between them. The study included 25 Alzheimer's patients and 25 control subjects, for a total of 50 individuals. The study measured the serum PON1 activity and other biochemical parameters and carotid atherosclerotic plaque values of the participants. The mean paraoxonase activity (31.06±2.31U/L) was significantly lower in the Alzheimer's group compared to the control group (59.05±7.05U/L) (P<0.001). Nonetheless, the carotid plaque values were significantly higher in the patient group (3.02±0.52mm) compared to the control group (1.84±0.45mm) (P<0.001). Furthermore, there was a negative correlation (81.0%) between PON1 activity and carotid plaque in the overall study group (P<0.05). Also serum homocystein level was higher in the patient group (22.15±7.05) compared to the control group (13.30±3.32). In conclusion, our findings show inverse association between PON1 activity and carotid atherosclerosis in Alzheimer patients: the lower the PON1 activity the more progressed the atherosclerotic process in AD.
低对氧磷酶1(PON1)活性和颈动脉粥样硬化被认为是痴呆的重要危险因素。然而,迄今为止的研究未能充分阐明PON1、颈动脉粥样硬化与痴呆之间的关系。本研究旨在测量阿尔茨海默病患者的颈动脉粥样硬化情况和PON1活性,并评估它们之间的关系。该研究纳入了25例阿尔茨海默病患者和25例对照受试者,共50人。研究测量了参与者的血清PON1活性、其他生化参数以及颈动脉粥样硬化斑块值。与对照组(59.05±7.05U/L)相比,阿尔茨海默病组的平均对氧磷酶活性(31.06±2.31U/L)显著降低(P<0.001)。尽管如此,患者组的颈动脉斑块值(3.02±0.52mm)显著高于对照组(1.84±0.45mm)(P<0.001)。此外,在整个研究组中,PON1活性与颈动脉斑块之间存在负相关(81.0%)(P<0.05)。患者组的血清同型半胱氨酸水平(22.15±7.05)也高于对照组(13.30±3.32)。总之,我们的研究结果表明,阿尔茨海默病患者中PON1活性与颈动脉粥样硬化呈负相关:PON1活性越低,AD中的动脉粥样硬化进程越严重。